Search research articles
Contact Us
Filters
Showing results (651-660 of 716) with videos related to
Page
of 72
Sort By:
Heart (British Cardiac Society)
|
November 7, 2007
Triplane tissue Doppler imaging: a novel three-dimensional imaging modality that predicts reverse left ventricular remodelling after cardiac resynchronisation therapy
N R Van de Veire, C-M Yu, N Ajmone-Marsan, et al.
Scientific Reports
|
November 23, 2022
Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events
Jessica A Regan, Lauren K Truby, Usman A Tahir, et al.
Circulation
|
June 20, 2017
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)
Neha J Pagidipati, Ann Marie Navar, Karen S Pieper, et al.
The Lancet. Diabetes & Endocrinology
|
December 10, 2017
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
M Angelyn Bethel, Rishi A Patel, Peter Merrill, et al.
Redox Biology
|
October 30, 2020
Resolving the paradox of ferroptotic cell death: Ferrostatin-1 binds to 15LOX/PEBP1 complex, suppresses generation of peroxidized ETE-PE, and protects against ferroptosis
Tamil S Anthonymuthu, Yulia Y Tyurina, Wan-Yang Sun, et al.
Diabetes Care
|
November 24, 2019
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
M Angelyn Bethel, Robert J Mentz, Peter Merrill, et al.
Diabetologia
|
August 6, 2009
Intensive glucose control and macrovascular outcomes in type 2 diabetes
, F M Turnbull, C Abraira, et al.
Analytical Chemistry
|
September 21, 2017
Development of a Cigarette Tobacco Filler Standard Reference Material
Lane C Sander, Jeanita S Pritchett, Yasmine C Daniels, et al.
American Heart Journal
|
November 2, 2013
Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
Roberto Latini, Lidia Staszewsky, Jie-Lena Sun, et al.
Diabetes/Metabolism Research and Reviews
|
March 7, 2023
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes
Ernesto Maddaloni, Lucia Coraggio, Rocco Amendolara, et al.
Page
of 72
Search research articles
Search
Showing results (651-660 of 716) with videos related to
Sort By:
Page
of 72
Heart (British Cardiac Society)
|
November 7, 2007
Triplane tissue Doppler imaging: a novel three-dimensional imaging modality that predicts reverse left ventricular remodelling after cardiac resynchronisation therapy
N R Van de Veire, C-M Yu, N Ajmone-Marsan, et al.
Scientific Reports
|
November 23, 2022
Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events
Jessica A Regan, Lauren K Truby, Usman A Tahir, et al.
Circulation
|
June 20, 2017
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)
Neha J Pagidipati, Ann Marie Navar, Karen S Pieper, et al.
The Lancet. Diabetes & Endocrinology
|
December 10, 2017
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
M Angelyn Bethel, Rishi A Patel, Peter Merrill, et al.
Redox Biology
|
October 30, 2020
Resolving the paradox of ferroptotic cell death: Ferrostatin-1 binds to 15LOX/PEBP1 complex, suppresses generation of peroxidized ETE-PE, and protects against ferroptosis
Tamil S Anthonymuthu, Yulia Y Tyurina, Wan-Yang Sun, et al.
Diabetes Care
|
November 24, 2019
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
M Angelyn Bethel, Robert J Mentz, Peter Merrill, et al.
Diabetologia
|
August 6, 2009
Intensive glucose control and macrovascular outcomes in type 2 diabetes
, F M Turnbull, C Abraira, et al.
Analytical Chemistry
|
September 21, 2017
Development of a Cigarette Tobacco Filler Standard Reference Material
Lane C Sander, Jeanita S Pritchett, Yasmine C Daniels, et al.
American Heart Journal
|
November 2, 2013
Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
Roberto Latini, Lidia Staszewsky, Jie-Lena Sun, et al.
Diabetes/Metabolism Research and Reviews
|
March 7, 2023
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes
Ernesto Maddaloni, Lucia Coraggio, Rocco Amendolara, et al.
Page
of 72